VIELA BIO, INC. Stock-Based Compensation
VIELA BIO, INC. reported Stock-Based Compensation of $12.23 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-03-01
- VIELA BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $3.08M, a 118.91% increase year-over-year.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $3.35M, a 259.94% increase year-over-year.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $3.09M, a 376.23% increase year-over-year.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $2.71M, a 324.26% increase year-over-year.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $12.23M, a 237.32% increase from fiscal 2019.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $3.63M, a 92.92% increase from fiscal 2018.
- VIELA BIO, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $1.88M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $6.43M derived: sum of 2 quarters · filed 2021-03-01 | $9.52M derived: sum of 3 quarters · filed 2021-03-01 | $12.23M 10-K · filed 2021-03-01 |
| 2020-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $6.44M derived: sum of 2 quarters · filed 2020-11-10 | $9.15M 10-Q · filed 2020-11-10 | $10.55M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $5.80M 10-Q · filed 2020-08-12 | $7.20M derived: sum of 3 quarters · filed 2021-03-01 | $8.13M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $2.71M 10-Q · filed 2020-05-13 | $4.12M derived: sum of 2 quarters · filed 2021-03-01 | $5.05M derived: sum of 3 quarters · filed 2021-03-01 | $5.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.34M derived: sum of 2 quarters · filed 2021-03-01 | $2.99M derived: sum of 3 quarters · filed 2021-03-01 | $3.63M 10-K · filed 2021-03-01 |
| 2019-09-30 | $931.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.58M derived: sum of 2 quarters · filed 2020-11-10 | $2.22M 10-Q · filed 2020-11-10 | $2.83M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $648.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $1.29M 10-Q · filed 2020-08-12 | $1.90M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $639.00K 10-Q · filed 2020-05-13 | $1.25M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.88M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $1.27M 10-Q · filed 2019-11-14 |